We’re building a pipeline of targeted therapeutics and companion diagnostics to address unmet need in immune-mediated diseases. Our unique understanding of patient biology, coupled with our approach to therapeutics and companion diagnostics, positions us to develop potentially life-changing therapies for patients in need.
There is an urgent need for new therapies to treat immune-mediated diseases.
We believe our Precision-FirstTM therapeutic approach has the potential to have meaningful and immediate patient impact.
Liu et al. Hospital Deaths in Patients With Sepsis From 2 Independent Cohorts.
JAMA. 2014; 312(1):90–92. DOI:10.1001/jama.2014.5804
Rubenfeld et al. Hospital Volume and the Outcomes of Mechanical Ventilation.
NEJM. 2006; 355:41-50. DOI: 10.1056/NEJMsa053993
Sung et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021; 71: 209-249. DOI: 10.3322/caac.21660
Global report on the epidemiology and burden of sepsis: current evidence, identifying gaps and future directions. Geneva: World Health Organization; 2020. License: CC BY-NC-SA 3.0 IGO.